Us Bancorp \De\ Bio N Tech Se Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Bio N Tech Se stock. As of the latest transaction made, Us Bancorp \De\ holds 3,168 shares of BNTX stock, worth $363,591. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,168

Previous 4,678 32.28%

Holding current value

$363,591

Previous $555,000 35.14%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$99.72 - $122.68 $150,577 - $185,246	-1,510 Reduced 32.28%	3,168 $360,000
Q3 2024 Oct 28, 2024	SELL	$78.36 - $124.66 $1.65 Million - $2.62 Million	-21,012 Reduced 81.79%	4,678 $555,000
Q2 2024 Aug 06, 2024	BUY	$80.36 - $102.87 $134,442 - $172,101	1,673 Added 6.97%	25,690 $2.06 Million
Q1 2024 May 07, 2024	SELL	$88.96 - $112.35 $408,949 - $516,472	-4,597 Reduced 16.07%	24,017 $2.22 Million
Q4 2023 Feb 09, 2024	BUY	$90.91 - $112.75 $2.1 Million - $2.61 Million	23,119 Added 420.73%	28,614 $3.02 Million
Q3 2023 Nov 03, 2023	SELL	$98.5 - $125.08 $18,813 - $23,890	-191 Reduced 3.36%	5,495 $596,000
Q2 2023 Aug 09, 2023	BUY	$102.58 - $129.66 $67,600 - $85,445	659 Added 13.11%	5,686 $613,000
Q1 2023 May 09, 2023	BUY	$122.57 - $153.67 $44,125 - $55,321	360 Added 7.71%	5,027 $626,000
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $42,753 - $67,164	-361 Reduced 7.18%	4,667 $701,000
Q3 2022 Oct 27, 2022	SELL	$127.65 - $183.11 $49,911 - $71,596	-391 Reduced 7.22%	5,028 $679,000
Q2 2022 Aug 01, 2022	BUY	$123.25 - $186.24 $127,317 - $192,385	1,033 Added 23.55%	5,419 $808,000
Q1 2022 May 11, 2022	BUY	$126.25 - $231.85 $41,915 - $76,974	332 Added 8.19%	4,386 $749,000
Q4 2021 Feb 11, 2022	BUY	$216.64 - $362.52 $248,486 - $415,810	1,147 Added 39.46%	4,054 $1.05 Million
Q3 2021 Nov 10, 2021	BUY	$205.93 - $447.23 $598,638 - $1.3 Million	2,907 New	2,907 $793,000
Q2 2021 Aug 05, 2021	SELL	$113.32 - $241.49 $339 - $724	-3 Closed	0 $0
Q1 2021 Apr 28, 2021	SELL	$85.73 - $119.5 $48,351 - $67,398	-564 Reduced 99.47%	3 $0
Q4 2020 Feb 04, 2021	BUY	$72.71 - $129.54 $41,226 - $73,449	567 New	567 $46,000

Others Institutions Holding BNTX

# of Institutions

363

Shares Held

39.6M

Call Options Held

3.01M

Put Options Held

2.01M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.9B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account